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background:  Type 2 diabetes (DM) is known to be a risk factor for the development of coronary heart disease and a prognostic factor in 
myocardial infarction. Little is known about its impact on hospital and long-term outcome in the era of stringent reperfusion therapy of STEMI and 
NSTEMI.
methods: The OPTAMI registry (Optimized Therapy of Acute MI) enrolled consecutive patients with STEMI or NSTEMI in 33 centres (27 with cathlab) 
in Germany to document patient characteristics, acute therapy, hospital and 1-year outcome. We examined the impact of DM on outcome of STEMI 
and NSTEMI in the era of primary / early PCI.
results: A total of 3180 patients were enrolled into OPTAMI. The prevalence of DM was 23.4% in STEMI and 34.5% in NSTEMI. Patients with DM 
were older, more often female and had a significantly higher prevalence of comorbidities. The overall acute reperfusion rate was high, however 
diabetics were less likely to undergo reperfusion therapy in both STEMI and NSTEMI. No differences were found for hospital mortality between 
patients with or without DM in both STEMI and NSTEMI. However, 1-year-mortality was significantly higher in diabetics as compared to non-diabetics 
for both STEMI and NSTEMI
Conclusion: No difference was found in hospital mortality between diabetics and non-diabetics in the era of stringent reperfusion therapy. 
However, diabetics had significantly higher long-term mortality probably indicating the need for better secondary prevention treatment in this high 
risk population. 
 
STEMI NSTEMI
DM (n=381) No DM (n=1244) p-value DM (n=515) No DM (n=996) p-value
Age (y)
Females
Smoking
Hypertension
Hyperlipidemia
70
37%
29%
85%
50.3%
62
25.8%
44.6%
60.1%
34.8%
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
73
36.3%
18.7%
91.1%
59.4%
67
26.9%
32.8%
72.5%
43.1%
<0.0001
<0.001
<0.0001
<0.0001
<0.0001
Prior MI
Prior PCI
Prior CABG
Prior stroke
Renal failure
20.5%
18.9%
4.7%
8.7%
20.5%
13.6%
12.2%
3.5%
2.7%
6.1%
<0.01
<0.001
0.25
<0.0001
<0.0001
39.2%
34.1%
15.5%
12.3%
33.6%
26.8%
22.9%
10.1%
6.7%
13.1%
<0.0001
<0.0001
<0.01
<0.001
<0.0001
Cor-angio<48h
PCI
92.6%
83.7%
96.2%
86.8%
<0.01
0.13
80.4%
57.4%
87.8%
66.9%
<0.001
<0.001
Hosp. mortality
1-year mortality
7.2%
19.1%
5.6%
9.4%
0.26
<0.0001
6.2%
21.9%
5.0%
12.3%
0.33
<0.0001
